Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quetmo agent, quetmolimab, represents a novel approach aimed at PD-1. Early study data from the two programs, KANAb 001 and E-6011, reveal positive response in https://www.targetmol.com/compound/quetmolimab